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Our knowledge of the cellular aspects of immune phenomena has been increased in 
recent years by the realization that cooperatiion  between functionally distinct popu- 
lations of immunocompetent cells  appears  to be a  prerequisite  for specific  antibody 
production (1-6). The most extensively studied case of this type of cell-to-cell  inter- 
action has been exemplified  in the mouse by transfer experiments with suspensions of 
thymus-derived and bone marrow-derived cell,; for immune reponses to sheep erythro- 
cyte antigens (1, 3, 4). Similar thymus-marrow cooperation has been recently demon- 
strated in this species for other immunogens, including albumins (7, 8), immunoglobu- 
lins  G (9), other heterologous erythrocytes (10,  11), and the branched chain synthetic 
polypeptide poly-L-(Tyr,Glu)-poly-L-Pro--poly-L-Lys (12). 
The genetic control of immunological responsiveness has been shown to be due to a 
defect  at  the  immunocompetent  cell  level,  since  irradiated  low  responder  animals 
generated immune responses characteristic of high responders after injection of spleen, 
thoracic duct, peripheral blood, or fetal liver cells from high responder donors (13-17). 
In order to understand the mechanism by which genetic regulation of immunological 
responsiveness functions, it is necessary to determine in which immunocompetent cell 
population the genetic defect is expressed.  Previous transfer experiments with mice 
have not established the cellular origin of this genetic control. 
Genetic  control of responses  specific  for  two  distinct  immunocompetent  regions 
within  the  synthetic polypeptide poly-L-(Phe,Glu)-poly-L-Pro--poly-L-Lys, denoted 
(Phe,G)-Pro--L, has been reported  (18,  19).  SJL mice were high responders  to the 
Pro--L portion of this immunogen, but low responders to (Phe, G), whereas DBA/1 
mice were high responders to the (Phe, G) determinant, but low responders to Pro--L. 
In two preceding publications, it was demon,~trated  by limiting  dilution experiments 
that expression of such genetic control appeared to be due to insufficient numbers of 
relevant immunocompetent splenic precursors,  stimulated by the immunogens (20, 21). 
In  experiments  reported  here,  cooperation  between  thymocytes  and  bone 
marrow cells was demonstrated for immune responses to (Phe, G)-Pro--L by cell 
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transfers  in  mice.  By  limiting  dilution  experiments  in  which  a  nonlimiting 
number  of thymocytes was mixed with several limiting inocula of marrow cells 
and  transferred  into  syngeneic,  irradiated  recipients,  it  was  found  that  the 
genetic defect  of the immune  response  to  (Phe, G)  in  SJL mice and  to Pro--L 
in the DBA/1  strain could be accounted for by differences in the relative number 
of stimulated  immunocompetent  cells found  in  the  bone marrow  of  these  two 
mouse strains.  In contrast,  experiments  involving the  transfer  of graded  num- 
bers  of  thymocytes  with  an  excess  of marrow  cells indicated  that  the  genetic 
control of antibody responses  to  (Phe, G)-Pro--L in SJL and DBA/1  mice can- 
not  be  attributed  to  a  deficiency in  the  relative numbers  of  available  thymo- 
cytes.  This  study  also shows  by means  of two-step  limiting dilutions  that  the 
genetic defect is not due to differences in the proliferative capacity of relevant 
thymocytes  after  stimulation  with  immunogen.  Finally,  the  results  indicate 
that  a  single population of thymocytes and of thymus-derived  cells is triggered 
by  (Phe,G)-Pro--L,  and  that  these  cells  do  not  distinguish  between  the  two 
immunopotent  areas,  namely  (Phe,G)  and Pro--L. 
Materials and Methods 
Mice.--Inbred SJL and DBA/1 mice of both sexes, 9-11 wk of age, were used as recipients, 
and females 8-10 wk old were used as donors of thymus and bone marrow cells.  Both mouse 
strains  were  obtained  from  the  Experimental  Animal  Unit,  The  Weizmann  Institute  of 
Science. 
Irradiation.--Recipient  mice to be injected with  thymocytes and/or bone  marrow  cells 
were exposed  to 700-800 R  of whole body X-irradiation  (250 kv peak,  15 ma, with 0.5  mm 
Cu and  1.0 mm AI, source  to target distance 50 cm, and  exposure rate of  60  R/min)  in a 
rotating lucite chamber. 
Cell Suspensions  and  Transfers.--Suspensions  of  bone  marrow  cells were  prepared  by 
flushing  marrow  from  the  femurs  and  tibiae  of  donors  with  cold Eagle's medium  (Grand 
Island  Biological Co., Grand  Island,  N.  Y.).  Clumps  of cells were dispersed by aspiration 
through a  23 gauge needle.  Particulate matter was removed by filtration through 200 mesh 
per inch stainless steel screen. 
Thymocyte  suspensions  were prepared  by  mincing  the  thymuses  with  scissors  in  cold 
Eagle's medium. The cells in the fragments were dispersed by repeated aspiration through the 
orifice of a 2.5 ml syringe. The cells were filtered through a stainless steel screen.  Cell suspen- 
sions containing thymus-derived cells were prepared from the spleens of irradiated recipients 
which had been injected 1 wk earlier with syngeneic thymocytes (22, 23). These suspensions 
were then diluted  and  mixed with syngeneic marrow for injection so that  a  1 ml inoculum 
would contain 2 X  107 marrow cells and ~, 1/~, 1/i6, 1/~2, or 1/64 of a spleen equivalent con- 
tMning thymus-derived cells. 
The concentration of each cell preparation was estimated by repeated sample counting of 
nucleated cells using a hemocytometer. Suspensions of thymocytes and/or marrow cells were 
injected into the lateral tail vein of recipients in 1 ml volumes within 4 hr after irradiation. 
The recipients were injected intraperitoneally with 50 USP units of heparin  a few minutes 
before cell inoculation to prevent embolism. 
Immunization.--The  immunogen  used  in  this  study  was  poly-L-(Phe,Glu)-poly-L-Pro-- 
poly-L-Lys,  702, abbreviated  (Phe,G)-Pro--L.  The  synthesis  and  characterization  of  this 
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and/or bone marrow cells were given a single  intraperitoneal injection of 10/zg of (Phe, G)- 
Pro--L in complete Freund's adjuvant (Difco Lzboratories, Detroit, Mich.). For experiments 
involving retransfers of thymus-derived cells, both the primary recipients injected with thymo- 
cytes and the secondary recipients injected with thymus-derived and marrow cells were im- 
munized intraperitoneally with  13 ~tg (Phe,G)-Pro--L in complete Freund's adjuvant 24 hr 
after celt transfer. 
Passive Microhemagglutination Assay.--The  passive  microhemagglutination  tests  per- 
formed have been described  elsewhere  (21),  using the synthetic polypeptides poly-L-(Tyr, 
Glu)-poly-L-Pro--poly-L-Lys, 701, (T,G)-Pro--L  (24),  and  poly-L-(Phe,Glu)-poly-DL-A]a-- 
poly-L-Lys,  223, (Phe,G)-A--L  (25). Separate  hemagglutination  assays  were performed  on 
the sera from individual recipients 14 days after immunization (the time of maximum antibody 
titers) using (Phe, G)-A--L- and  ( F, G)-Pro--L-coated erythrocytes, respectively, for detect- 
ing responses  to the (Phe, G) and Pro--L regions of (Phe, G)-Pro--L. 
Experimental Design and Statistical Methods.--Limiting dilution  experiments  were  per- 
formed to estimate the frequencies of relevant immunocompetent precursors in thymus and 
bone marrow cell suspensions.  Since an inoculum containing both thymus and marrow cells is 
required  (under  the experimental conditions used here)  for the production of anti-(Phe,G) 
and anti-Pro--L responses  (see below), graded numbers of bone marrow cells were mixed with 
a  constant,  nonlimiting number  of 108  thymocytes.  Conversely, limiting inocula of thymo- 
cytes were mixed with an excess of 20 X  106 marrow cells. These cell dilutions were made to 
critically reduce the frequency of one relevant cell type in the recipients, while providing an 
excess of the other cell (26, 27). Limiting dilution experiments for thymus-derived cells were 
performed by a  two-step procedure similar to that  reported for sheep erythrocyte antigens 
(23). Irradiated recipient mice were injected with 3.5 X  107 thymocytes followed by (Phe,G)- 
Pro--L  24  hr  later.  6  days  after  thymocyte injection, pooled cell suspensions  (containing 
thymus-derived cells) were made from the primary recipient spleens.  Graded fractions of this 
suspension  ranging from 1/~ to 1/64 of a spleen equivalent were mixed with 2 X  107 marrow 
cells and  retransplanted  into irradiated,  test recipients, followed by  (Phe,G)-Pro--L  24 hr 
later.  Under the conditions outlined above, whether or not a functional immunocompetent 
response unit will be formed depends mainly on the number of limiting cells transferred. The 
Poisson model and the method of maximum likelihood were adopted for the Golem computer 
at the Weizmann Institute of Science and used to estimate the probability values and confi- 
dence intervals (28). The hypothesis that  (Phe, G)-Pro--L stimulated a single population of 
thymocytes and thymus-derived cells relevant for generating anti-(Phe,G)  and  anti-Pro--L 
responses  was tested by subjecting the limiting dilution results to the Yates' corrected chi- 
square test for association of responses  assayed with (Phe, G)-A--L or (T, G)-Pro--L. 
RESULTS 
Thymus-Bone  Marrow  Cell  Cooperation for  (Phe,G)-Pro--L  Responses.--In 
order to investigate the possible contribution  of thymus and/or marrow cells in 
expression  of  the  genetic  control  of  immune  responses  to  (Phe,G)-Pro--L,  it 
was  first  necessary  to  demonstrate  that  cell-to-cell interaction  is  required  for 
(Phe, G)- and Pro-L-specific antibody  responses.  Heavily irradiated  SJL and 
DBA/1  mice  were  injected  with  thymocytes,  or  bone  marrow  cells,  or  with 
thymus  and  marrow  cells taken  from  syngeneic  donors,  and  immunized  with 
(Phe, G)-Pro--L 24 hr later. 2 wk after cell transfer, at the time of peak antibody 
titers,  the  recipients  were  bled  and  their  sera  were  individually  assayed  for 
(Phe,G)-  and  Pro--L-specific  antibodies.  The  data  obtained  using  the  SJL 144  CELLULAR  BASIS  OF  GENETIC  CONTROL  OF  IMMUNITY 
and DBA/1  strains were pooled (since the cell cooperatin results were similar) 
and are shown in Fig. 1.  Most of the recipients injected with either thymus or 
marrow cells did not generate responses in the sera detectable with erythrocytes 
coated either with  (Phe,G)-A--L or with  (T,G)-Pro--L at dilutions of 1:4.  Of 
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FIG. 1. Hemagglutination titers of SJL  and DBA/1  recipient sera after irradiation and 
injection of (Phe, G)-Pro--L and 108 thymocytes (symbol []), 20 X  10G marrow cells (symbol 
[~ ), or 100 X  10 ~ thymocytes and 20 )< 106 marrow cells (symbol ~) frmn syngeneic donors. 
The  sera were  assayed  with  (Phe,G)-A--L or  (T,G)-Pro--L. The  vertical axis  plots the 
number of recipient sera showing a given hemagglutination titer. 
the  16  SJL  mice  injected  with  bone  marrow  cells,  only  one  gave  a 
detectable  response  to  Pro--L.  2  of  the  17  DBA/1  marrow  recipients  re- 
sponded to (Phe,G)  with titers of 1:8  and  1 of 17  gave a  similar response to 
Pro--L.  None  of the  9  DBA/1  mice  injected  with  thymocytes  generated  de- 
tectable antibody responses for the two specificities. In contrast, most recipients EDNA  MOZES  AND  G.  M.  SHEARER  145 
from both mouse strains inoculated with a  mixture containing 60-100  X  106 
thymocytes and 20 X  l0  s marrow cells generated responses specific for (Phe, G) 
and Pro--L at serum dilutions greater than  1:4. Of the 21  SJL recipients in- 
jected with the cell mixtures, 13 gave hemagglutination titers with  (Phe,G)- 
A--L at a dilution of 1:8, 2 at 1:16, and 5 at 1:128. From the same sera assayed 
with (T,G)-Pro--L, 6 were positive at 1:8, 10 at 1:16, and 5 at 1:128. From a 
total of 22  DBA/1  thymus-marrow recipients,  11  gave hemagglutination  at 
1 : 8, 8 at 1 : 16, and 1 at 1 : 32, when the sera were tested with (Phe, G)-A--L. The 
same sera titered with (T, G)-Pro--L resulted in 9 mice showing a titer at 1:8, 
9 at 1:16, and 1 at 1:32. These results indicate that thsanocytes and marrow 
cells interact synergistically to generate (Phe, G)- and Pro--L-specific responses 
in both mouse strains. 
Frequency of  Responses in  SJL  and  DBA/1  Recipients  Injected  with  10  s 
Thymocytes and Graded Numbers  of Marrow Cells.--Expression  of the genetic 
control of antibody responses to (Phe, G)-Pro-L (21) and to a related branched 
chain,  synthetic  polypeptide,  (T,G)-Pro--L  (20),  has  been  correlated  with 
differences in  the relative numbers of limiting precursor cells detected in  the 
spleens of inbred mouse strains.  Suspensions of immunocompetent cells from 
other lymphoid sources which express this immune defect should also exhibit 
differences in  the  frequencies of the  relevant precursors in high  and low re- 
sponder mice. On the other hand, limiting dilutions of lymphoid cells not ex- 
pressing the defect would be expected to generate about equally frequent re- 
sponses in both high and low responder animals.  Since both thymocytes and 
marrow cells  are required to generate antibodies specific for (Phe, G)  and for 
Pro--L (see Fig.  1),  limiting dilutions of one of these cell populations in  the 
presence of a  constant excess number of the other cell provides a  convenient 
approach for investigating the contribution of thymus and/or bone marrow in 
expression of the genetic control of immunity. 
In  the present  study,  irradiated  SJL and DBA/1  mice were injected with 
graded inocula of marrow cells (0.05-20 X  106) mixed with l0  s thymocytes pre- 
pared  from  syngeneic  donors.  The  recipients  were  injected  with  10  ~g 
of (Phe,G)-Pro--L in complete Freund's adjuvant 1 day later. 2 wk after cell 
transfer, at the time of peak antibody titer, the recipients were bled and their 
sera assayed for (Phe, G)- and Pro--L-specific antibodies using (Phe, G)-A--L- 
and  (T,  G)-Pro--L-coated erythrocytes, respectively. The sera were classified 
as "positive" only if antibodies specific for (Phe, G) or Pro--L were detected at 
dilutions greater than 1:4 (reference 21 and Fig. 1). The results of 106 SJL and 
107 DBA/1 surviving recipients are shown in Tables I and II and in Figs. 2 and 
3. Similar to the results obtained with limiting inocula of spleen cells from unim- 
munized syngeneic donors (21), differences of about 5-fold were observed in the 
frequencies of (Phe,G)- and Pro--L-specific responses in both strains of mice. 
For the SJL strain (low responder to [Phe, G]), an inoculum of 1 X  106 marrow 
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whereas  the  transfer  of  more  than  8  X  106  cells  was  required  to  gener- 
ate  (Phe,G)  responses  in  an  equivalent  proportion  of  mice  (Table  I).  Con- 
versely, 1  X  106  syngeneic marrow cells generated positive (Phe,G)  responses 
in two-thirds of the DBA/1  recipients (low responders to Pro--L), whereas 8  X 
106  transferred cells were required to yield a  similar frequency of sera positive 
TABLE  I 
Percentage  of Positive  Sera  in  Irradiated  SJL  Recipients  14  Days  After  Injection  of 
(Phe,G)-Pro--L,  I0  s  Thymocytes,  and  Graded Numbers  of Bone  Marrow  Cells from 
Syn~.eneic Donors 
Sere of recipients 
titeredwith 
(Phe, G)-A--L 
(T, G)-Pro--L 
No.  of 
marrow  Fraction 
cells  of positive 
trans-  sera in 
planted  recipients* 
(X106) 
-  -  0/5 
0.c  0/9 
0.1 
0.2  0/16 
0.5  1/7 
1.0  6/21 
2.0  6/20 
4.0  4/11 
8.0  9/21 
0.0  6/6 
0.0  1/9 
{). 1  1/5 
~).2  8/16 
a.5  4/7 
1.0  14/21 
2.0  14/20 
.0  9/11 
.0  18/21 
20.0  6/6 
Percentage 
of positive 
sera in 
recipients* 
0 
0 
0 
14.3 
28.6 
30.0 
36.4 
42.8 
100.0 
11.1 
20.0 
50.0 
57.1 
66.7 
70.0 
81.8 
85.6 
100.0 
Probability  of 
positive sera 
per 10  6 cells~ 
0.14 
(0.094  0.20)§ 
0.57 
(0.41-0.80)§ 
Precursor cell 
frequency 
(Xl0-q 
1/7.3 
(1/5.0-1/11)§ 
1/1.7 
(1/1.2-1/2.4)§ 
* Donor-derived  responses showing titers at dilutions greater than 1:4 m recipient sera. 
:~ Estimates of probability values were based on the Poisson model (28). 
§ 95% confidence intervals shown  in parentheses. 
for  Pro--L  (Table II). For a  more accurate  evaluation of the frequency  data 
which considers all inocula tested, the probability values that l06 marrow cells 
(in  the presence of a  nonlimiting number  of thymocytes)  would generate de- 
tectable (Phe,G)  or Pro--L responses were estimated using the Poisson model 
(28).  These probability values for SJL  marrow  donors were 0.14  and 0.57  for 
(Phe, G)  and Pro--L, respectively, and the corresponding frequencies for limit- 
ing marrow precursors were 1/~.  a  X  106  and 1/~.  7  X  106  (Table I, Fig. 2). The EDNA  MOZES  AND  G.  M.  SHEARER  147 
95%  confidence  intervals  did  not  overlap  for  the  responses  assayed  with 
(Phe, G)-A--L. The probabilities that  106 DBA/1  marrow cells would contain 
precursor cells relevant for generating  (Phe,G)  or Pro--L responses were 0.53 
and  0.15,  respectively,  and  the  precursor  frequencies  were  estimated  to  be 
1~.9  X  106 for (Phe,G)  and 1/6.  5  X  106 for Pro--L (Table II, Fig.  3).  These 
differences were significant at the 0.05 level. The frequency data shown here in- 
TABLE II 
Percentage of Positive Sera in  Irradiated DBA/I  Recipients 14 Days After Injection of 
(Phe,G)-Pro--L, IO  s Thymocytes, and  Graded Numbers of Bone Marrow Cells from 
Syngeneic Donors 
Sera of recipients 
titered with 
(Phe, G)-A--L 
(T, G)-Pro--L 
Fraction 
of positive 
sera in 
recipients* 
2/11 
3/13 
10/26 
5/8 
8/11 
14/17 
9/1~ 
10/10 
o/11 
o/13 
3/26 
3/8 
3/11 
8/17 
7/11 
9/10 
Percentage  Probability of 
of positive 
sera in  positive sera 
recipients*  per lO  s cel]s:~ 
18.2 
23.1 
38.5 
62.5  0.53 
73.0  (0.37-0.75)§ 
82.4 
81.8 
100.0 
0 
0 
11.5 
37.5  0.15 
27.3  (0.10-0.23)§ 
47.1 
63.6 
90.0 
Precursor cell 
frequency 
(X10-~) 
1/1.9 
(1/1.3-1/2.7)§ 
1/6.5 
(1/4.4-1/9.7)§ 
*  Donor-derived responses showing titers at dilutions greater than 1:4 in recipient sera. 
Estimates of probability values were based on the Poisson model (28). 
§ 95% confidence intervals shown in parentheses. 
dicate that the low responsiveness of SJL mice to (Phe, G) can be accounted for 
by a 5-fold reduced number of detected marrow precursors when compared with 
marrow  precursors  generating  the  Pro--L  response.  Conversely,  the  5-fold 
lower number of immunocompetent marrow cells generating Pro-L responses, 
compared with those generating  (Phe, G) responses in DBA/1  mice, is corre- 
lated with the fact that the DBA/1 strain is a poor responder to Pro--L. 
Frequency of Responses in SJL and DBA/1  Recipients Injected with 2  >( 10  z 
Marrow Cells  and  Graded Numbers  of Thymocytes.--In  order  to estimate  the 148  CELLULAR  BASIS  OF  GENETIC  CONTROL  OF  IMMUNITY 
relative  numbers  of  thymus  cells  stimulated  by  (Phe,G)-Pro--L,  graded 
inocula of syngeneic thymocytes (0.5-100 X  106) were mixed with 2  X  107 bone 
marrow  cells and  injected  into groups of heavily irradiated SJL  and DBA/1 
mice. The recipients were immunized with  (Phe,G)-Pro--L and  their sara as- 
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FIG. 3.  Percentage of positive sera in DBA/1 recipients when assayed with (Phe, G)-A--L 
(symbol  O) or (T,G)-Pro--L (symbol O) after irradiation and injection of (Phe,G)-Pro-L, 
10 s thymocytes, and graded numbers of bone marrow cells from syngeneic donors. 
sayed for  (Phe, G)  and  Pro--L  responses  as  described above. The  results ob- 
tained from  116  SJL and  116 DBA/1  survivors are summarized  in Tables III 
and IV and in Figs. 4  and 5. In contrast to the results obtained with  limiting 
numbers  of transferred spleen  (21)  or bone marrow  cells (see  above),  no  sig- 
nificant differences were detected when the responses  were limited by the num- 
bers of thymocytes transferred for  either specificity in these two  mouse strains. 
A transfer of 10-20 X  106 SJL thyrnocytes was required to generate  (Phe, G) or EDNA  MOZES  AND  G.  M.  SItEARER  149 
Pro--L responses in two-thirds of the recipients. The probability values that 106 
SJL thymocytes would contain immunocompetent cells that generated positive 
(Phe, G) or Pro--L responses was calculated  to be 0.089 and 0.10,  respectively. 
The corresponding precursor frequencies were estimated to be 1~1  X  106 and 
1/~0 X  106 for these two specific§ties,  and the 95%  confidence intervals over- 
TABLE III 
Percentage of Positive  Sera  in  Irradiated  SJL  Recipients  14  Days  After  Injection  of 
(Phe,G)-Pro--L, 2  X  10  v Bone  Marrow  Calls, and  Graded  Numbers  of  Thymocytes 
from Syngeneic Donors 
Sera of recipients 
titered with 
(Phe, G)-A--L 
(T, G)-Pro--L 
No. of 
:hymo- 
cytes 
trans- 
planted 
(XlO6) 
0.5 
1.0 
2.5 
5.0 
10.0 
20.0 
40.0 
60.0 
0.5 
1.0 
2.5 
5.0 
10.0 
20.0 
40.0 
60.0 
Fraction 
of positive 
sera in 
recipients* 
1/6 
7/21 
7/21 
7/13 
10/18 
10/13 
12/14 
9/10 
1/6 
7/21 
9/21 
8/13 
lO/18 
10/13 
14/14 
10/10 
Percentage 
of positive 
sera in 
recipients* 
16.7 
33.3 
33.3 
53.8 
55.5 
77.0 
85.7 
90.0 
16.7 
33.3 
42.9 
61.5 
55.5 
77.0 
100.0 
100.0 
Probability of 
positive sera 
per l0  s cells:~ 
O. 089 
(0.065-0.12)§ 
0.10 
(0.074-0.14)§ 
Precursor cell 
frequency 
(X10  -6) 
1/11 
(1/8. I-1/15)§ 
1/10 
(1/7.1-1/14)§ 
* Donor-derived responses showing titers at dilutions greater than 1:4 m recipient sera. 
Estimates of probability values were based on the Poisson model (28). 
§ 95% confidence intervals shown in parentheses. 
lapped (Table III and Fig. 4). In order to obtain an equivalent proportion of 
positive sera in the DBA/1  strain,  about 20  X  106 thymocytes had to be in- 
jected. The calculated probabilities were 0.051  and 0.053 and the corresponding 
frequencies were 1/~0 X  106 and }/19 X  106 for (Phe,G)  and Pro-L responses 
(Table IV and Fig.  5).  No differences were found between  the  (Phe,G)  and 
Pro--L thymocyte precursor frequencies within the mouse strains, and the 1.9- 
fold frequency differences observed between the strains were not significant. The 
relationship between the number of thymocytes injected and the proportion of 
positive recipients generally followed the predictions of the Poisson model, al- 150  CELLULAR BASIS OF  GENETIC CONTROL OF  IMMUNITY 
though for the DBA/1  strain some divergence from the expected frequencies 
was  observed at  the  lower inocula. These variations could have been due  to 
fluctuations in the numbers of thymocytes injected in repetitive experiments. 
Frequency of Responses in SJL and DBA/1 Recipients Injected with 2  X  107 
Marrow Cells and Dilutions of Thymus-Derived Cdls in a Two-Step Experiment. 
TABLE  IV 
Percentage of Positive Sera in Irradiated DBA/1 Recipients 14 Days After Injection of 
(Phe,G)-Pro--L, 2 X  i07 Bone Marrow Cells, and Graded Numbers of Thymocytes  from 
Syngeneie Donors 
Sera of recipients 
titered with 
(Phe, G)-A--L 
(T, G)-Pro--L 
NO.  of 
thymo- 
cytes 
traus- 
planted 
(X109 
0.5 
1.0 
2.5 
5.0 
10.0 
20.0 
40.0 
60.0 
100.0 
0.5 
1.0 
2.5 
5.0 
10.0 
20.0 
40.0 
60.0 
100.0 
Fraction 
of positive 
sera in 
recipients* 
1/9 
s/is 
2/6 
10/21 
9/17 
7/11 
8/12 
10/12 
10/10 
1/9 
4/lS 
2/6 
10/21 
9/17 
7/11 
8/12 
10/12 
9/10 
i 
Percentage [  Probability  of 
of positive  positive  sera 
sera in  per tO  o  cells~  recipients* ] 
11.1 
27.7 
33.3 
47.6 
53.0 
63.6 
66.7 
83.3 
100.0 
11.1 
22.2 
33.3 
47.6 
53.0 
63.6 
66.7 
83.3 
90.0 
0.051 
(0.036-0.073),. 
Precursor cell 
frequency 
(Xl0-~) 
1/20 
(1/14-1/28)§ 
0.053  !  1/19 
(0.037-0.074)}  (1/14  1/27)§ 
i 
*  Donor-derived responses showing titers  at dilutions greater than 1:4 in recipient sera. 
3~ Estimates of probability values were based on the Poisson model (28). 
§ 95% confidence intervals  shown in parentheses. 
The possibility has to be considered that the genetic defect might not be due to 
differences in the initial numbers of potentially responding thymocytes, but that 
after cell transfer and immunization, thymocytes specific for the high-respond- 
ing determinant could proliferate more rapidly than those specific for the low- 
responding determinant. Were this to be the case, a greater number of thymus- 
derived descendent cells specific for Pro--L would be expected than the number 
specific for (Phe, G) in SJL mice. Conversely, a  higher frequency of (Phe, G)- EDNA  MOZES  AND  G.  M.  SHEARER  151 
specific than Pro--L-specific thymus-derived cells would be expected in DBA/1 
mice. The proliferative capacity of thymocytes stimulated  by sheep erythro- 
cytes has been estimated by a  two-step limiting dilution  assay (23).  We have 
used a  similar approach for (Phe, G)-Pro--L by injecting irradiated mice with 
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(symbol O) or (T,G)-Pro--L  (symbol 0) after irradiation and injection of (Phe,G)-Pro--L, 
2 X 107 bone marrow cells, and graded numbers of thymocytes from syngeneic  donors. 
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FIG. 5.  Percentage of positive sera in DBA/1 recipients when assayed with (Phe, G)-A--L 
(symbol ©) or (T,G)-Pro--L  (symbol O) after irradiation and injection of (Phe,G)-Pro--L, 
2 X 107 bone marrow cells, and graded numbers of thymocytes from syngeneic  donors. 
35  X  106 syngeneic thymocytes and  (Phe, G)-Pro--L. For both mouse strains 
an inoculum of this size would be expected to contain  an average of 2-4 de- 
tectable thymic precursors  (see Tables III and IV).  7  days after thymocyte 
transfer, during which time the relevant thymus population proliferated (22, 23, 
29),  recipient  spleens containing  thymus-derived cells were  removed, pooled, 
and suspensions made. These cell suspensions were serially diluted, mixed with 
2 X  107 syngeneic bone marrow cells,  and injected into a second group of test 152  CELLULAR  BASIS  OF  GENETIC  CONTROL  OF  IMMUNITY 
recipients with (Phe, G)-Pro--L. Sera from the test recipients were individually 
assayed 12 days later, and the results are summarized in Table V and Fig. 6. No 
differences were detected by dilution of thymus-derived cells in either strain for 
the (Phe,G)- or Pro--L-specific responses. Sera from about two-thirds of the 
SJL and DBA/1 test recipients were positive for both specificities when }/8 of a 
spleen equivalent containing thymus-derived cells was transferred with an ex- 
TABLE V 
Percentage of Positive Sera in Irradiated SJL and DBA /1 Test Recipients After Injection 
of (Phe,G)-Pro--L, 2 )< 107 Syngeneic Marrow Cells, and Graded Fractions of Spleens 
Containing Thymus-Derived Cells* 
Fraction of  Recipient sera titered with (T, G) Pro--L  Recipient sera titered with (Phe,G)-A--L 
primary 
spleen  [ 
retrans-  Fraction of  Percentage  Probability of  Fraction of  Percentage  Probability of 
planted with  positive  of positive  positive sera;~  positive  of positive  positive sera$ 
marrow  sera  sera  sera  sera 
1/16 
1/8 
1/4 
1/64 
1/32 
1/16 
1/8 
I/4 
7/13 
8/13 
5/7 
2/9 
3/9 
7/14 
lO/15 
9/14 
53.8 
61.5 
71.4 
22.2 
33.3 
50.0 
66.7 
64.4 
SJL strain 
i  7/13 
0.11  8/13 
(0.071-0.18)§  5/7 
DBA/1 strain 
2/9 
3/9 
0.076  7/14 
(0.051-0.11)§  10/15 
[  9/14 
53.8 
61.5 
71.4 
22.2 
33.3 
50.0 
66.7 
64.4 
0.11 
(0.071-0.18)§ 
0.076 
(0.051-0.11)§ 
* Primary recipients were injected with 35 X  106 thymocytes and 10 #g of (Phe, G)-Pro--L 
24 hr later. Fractions of thymus-derived cells that lodged and proliferated in spleens  were 
retransplanted into test recipients 7 days later with marrow cells. Test recipients  were im- 
munized with 10 #g of (Phe,G)-Pro--L 24 hr later. 
:~ Probability of obtaining a positive test recipient sera per 1/100 of retransplanted primary 
spleen containing thymus-derived cells. 
§ 95% confidence limits shown in parentheses. 
cess of marrow,  irrespective of whether  the  mouse  strain  under  study  was  a 
high or a  low responder to the determinants assayed. Statistical treatment  of 
the data yielded identical probability values for the two specificities within each 
strain (Table V), and slight but insignificant differences (0.11 for SJL and 0.076 
for DBA/1)  in the probabilities between the strains. 
Chi-Square Analysis of (Phe, G)- and Pro--L Specific Responses from Thymo- 
cyte  and  Thymus-Derived  Cell  Limiting  Dilutions.--In  order  to  determine 
whether the equally frequent dilutions of (Phe,G)  and Pro--L responses were 
the result of two separate but superimposed curves (one responsible for generat- 
ing (Phe,G)-specific and the other Pro--L-specific responses), or  whether  the 
responses to both  determinants were the  result of a  single curve  (indicating a EDNA  MOZES  AND  G.  1Y[. SHEARER  153 
common thymic precursor cell for both  specificities), the frequency data from 
individual recipients were  subjected  to  a  chi-square  test  for  independence of 
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FIG. 6.  Percentage of positive sera in SJL  (symbol ©) and DBA/1  (symbol O)  test re- 
cipients when assayed with (Phe, G)-A--L or (T, G)-Pro--L after irradiation and injection of 
(Phe,G)-Pro--L,  2  X  107  bone marrow  ceils,  and  fractions of  repopulated  spleens  from 
irradiated primary recipients which had been injected with 35 X  106 thymocytes and (Phe, G)- 
Pro--L 1 wk earlier. All cell transfers were made in syngeneic recipients, 
TABLE VI 
Chi-Square Tests for Independence of (Phe,G)- and  Pro--L-Specific  Responses in Recipients 
of 20 X  106 Marrow Cells and Graded Numb.ers of Thymocytes or Thymus-Derived Cells, 
Immunized  with (Phe, G)-Pro.-L 
Response  detected in recipient sera 
titeredwith 
No. of sera tested for 
thymocytes in 
No.  of sera tested for 
thymus-derived cells in 
(T, G)-Pro--L  (Phe, G)-A--L  SJL  DBA/I  SJL  DBA/1 
+  +  38  33  18  28 
+  --  6  6  2  3 
--  +  12  5  2  3 
--  --  26  43  14  27 
Total number of sera compared*  82  87  36  61 
Chi-square values*  21.3  44.9  19.0  36.5 
* Results of  only those  inocula which  generated  appreciable numbers of  positive and 
negative recipient sera were used in the chi-square tests. 
:~ Yates' corrected  chi-square values in the table were  compared with 10.8, the critical 
value of X  2 statistic at the 0.001 level of significance. 
(Phe, G)  and Pro--L responses. Only results of those inocula in which appreci- 
able numbers of positive and negative sera were found (i.e. 1-40 X  106 thymo- 
cytes)  were used in this statistical test,  so as not to bias the data in favor of 
association of  responses.  The  results,  summarized in Table VI,  including the 
calculated chi-square values, indicate that there was association (i.e. lack of in- 154  CELLULAR  BASIS  OF  GENETIC  CONTROL  OF  IMMUNITY 
dependence) between the generation of (Phe, G)- and Pro--L-specific antibody 
responses, when these responses were limited by transferring critical numbers of 
either thymocytes or thymus-derived cells. For the SJL strains,  the calculated 
chi-square values were 21.3 and 19.0 for thymocytes and thymus-derived cells, 
respectively. For DBA/1  mice,  these  values  were  calculated  to  be  44.9  for 
thymocytes and 36.5  for thymus-derived cells. These calculated values are well 
above 10.8,  the critical value of chi-square at the 0.001 level of significance. All 
the comparisons are compatible with the hypothesis that responses to (Phe, G) 
and Pro--L are not  independent  of each other when the thymus-derived pop- 
ulation  of cells limits the response to (Phe, G)-Pro--L. 
DISCUSSION 
Evidence has been previously presented that expression of the genetic regula- 
tion of immune responses of inbred mouse strains to synthetic polypeptides built 
on multichain poly-L-proline can be correlated with  the  relative numbers  of 
antigen-sensitive units stimulated in cell transfer experiments involving spleen 
cells (20, 21). Since mouse spleens contain a mixture of immunocompetent cells 
of thymus and bone marrow origin (30-32), it was necessary to first establish 
thymus-marrow cell cooperation for (Phe, G)-Pro--L responses before investiga- 
tion of the cellular source of the genetic defect could be performed. The observa- 
tion  that  thymus  and  marrow  cells  were  needed  for  imnmne  responses  to 
(Phe, G)-Pro--L is in agreement with the work of Tyan et al. (33) which demon- 
strated that  thymectomized, irradiated, fetal liver-protected mice did not re- 
spond to a branched chain synthetic polypeptide.  Furthermore, it adds a syn- 
thetic immunogen to the growing list of natural antigens which  require cell-to- 
cell interaction for imlnune responses (1-11). 
Since both  thymus and marrow cells were necessary for  the  generation of 
anti-(Phe,G)  and anti-Pro--L responses, cell  suspensions from either of these 
organs which carry the defect might also be expected  to show differences in 
precursor frequencies in high and low responder mice. Such differences should 
be demonstrable by limiting dilution transfer in irradiated syngeneic recipients. 
The frequencies of immunocompetent precursors  in  the  marrow of SJL  and 
DBA/1  mice generating (Phe, G)- and  Pro-L-specific responses were similar 
to  results  reported  for  spleen  cell  suspensions  for  unimmunized  donors  of 
these  two  strains  (21).  About  five times  more precursors  were detected for 
Pro--L  than  for  (Phe,G)  in  the  marrow  of  SJL  donors  (high  responders 
to Pro--L). Conversely, in the DBA/1 high responder strain to (Phe,G), a 5- 
fold greater  number  of marrow  precursors  was  observed that  generated  re- 
sponses specific for (Phe,G) than for Pro--L. In contrast to the direct correla- 
tion obtained between the  strain-dependent immune response potentials and 
the relative numbers of immunocompentent precursors detected in bone marrow 
cells, no differences were observed in the frequencies of thymocytes relevant for EDNA  MOZES  AND  G.  M.  SHEARER  155 
generating (Phe, G) and Pro--L responses.  For each mouse strain the confidence 
intervals overlapped for the two specificities,  and the  1.9-fold  estimated fre- 
quency differences between the two mouse strains were not significant at the 
0.05 level. Therefore, although immunological responsiveness to (Phe, G)-Pro--L 
is genetically controlled in these two mouse strains, the differential expression of 
ability to respond was not seen when generation of (Phe, G)- and Pro--L-spe- 
cific antibodies was dependent on a  critical number of available  thymocytes. 
The main finding of this study is, thus, that the expression of the genetic con- 
trol, which had previously been correlated with a  reduced number of low re- 
sponder mouse spleen cells (20, 21), was also found to be a characteristic of bone 
marrow cells but not of thymocytes. The experimental design used in this report 
provides an approach for investigating the cellular basis of genetic regulation of 
immune responsiveness in syngeneic animals, and therefore avoids graft-host re- 
jection problems which could interfere with interpretation of the results. 
The use  of a  defined, synthetic immunogen  (which possesses  a  restricted 
number of antigenic determinants), in conjunction with the limiting dilution 
cell transfer in high and low responder mouse strains, provides an opportunity 
for investigating the specificity restriction of immunocompetent cells. The fact 
that many recipients given critical inocula of SJL marrow cells (with an excess 
of  thymus  cells)  exhibited  responses  positive  for  Pro--L  but  negative  for 
(Phe,G),  and  that  most  irradiated mice  injected with  limiting numbers  of 
DBA/1 marrow (with a nonlimiting number of thymocytes) produced (Phe, G)- 
specific but not Pro--L-specific responses, indicated that the least frequent cell 
type relevant for generating responses to  these polypeptide determinants in 
mouse bone marrow is committed for a  single  antigenic specificity. A  similar 
conclusion has been reached for the limiting cell type reactive with (Phe, G)- 
Pro--L in SJL, DBA/1, and F1 spleens (2I). The above findings are compatible 
with recent observations of others that immunocompetent cells in bone marrow 
can be specifically rendered tolerant (9) or specifically immunized (10, ll, 34), 
despite the fact that these marrow elements cooperate with "antigen-reactive 
cells" of thymus origin in order to elicit antibody production (3). The fact that 
thymocyte dilution  experiments  resulted  in  equally  frequent  responses  for 
(Phe,G)  and  Pro--L  in  the  two mouse  strains  could mean that there were 
two populations of thymocytes, one specific  for  (Phe,G)  and  the  other  for 
Pro--L, both of which were present in equal frequencies and stimulated by 
(Phe, G)-Pro--L. Alternatively, a single population of thymus cells could have 
been triggered by the immunogen which generated, via cooperation with mono- 
specific  marrow cells,  two distinct populations of antibodies, one specific  for 
(Phe,G), and the other specific for Pro--L (19).  Results of chi-square analysis 
of the limiting dilution data are compatible only with the second of these possi- 
bilities (see Table VI), since the transfer of the response to (Phe, G) was almost 
always accompanied by the transfer of the response to Pro--L in thymocyte di- 156  CELLULAR  BASIS  OF  GENETIC  CONTROL  OF  IMMUNITY 
lution experiments. The observation that (Phe, G) and Pro--L immune responses 
were associated in transfer experiments involving limiting numbers of thymo- 
cytes and an excess of bone marrow cells could be accounted for by one of the 
following possibilities: (a) that stimulation of a single population of thymocytes 
specific for only one of these determinants is sufficient to generate specific anti- 
body production to both  (Phe,G)  and Pro--L; or  (b)  that  the population of 
thymocytes relevant for generating  (Phe,G)  and Pro--L responses is specific 
for the intact (Phe, G)-Pro--L immunogenic macromolecule. From the experi- 
ments reported here, it is not possible to distinguish between these two mecha- 
nisms. However, if the thymocyte population were specific for only one of these 
immunopotent areas, but could generate specific antibodies for both regions via 
marrow cells, then one would have expected to detect (Phe,G) responses in re- 
cipients which  did not  generate Pro--L responses,  and vice versa.  Thus,  the 
strong association of (Phe,G) and Pro--L responses favors the second mecha- 
nism, i.e., that a single population of thymocytes is specific for the whole poly- 
peptide macromolecule. Differences in receptor specificity for  immunocompe- 
tent  cells  necessary  for  cell-mediated  immunity  and  antibody-forming  cell 
precursors have been recently reported (35). Furthermore, polyvalent specificity 
has  been  demonstrated for lymphocytes involved in cytotoxic reactions with 
allogeneic target ceils  (36,  37). This latter finding contrasts with the observa- 
tions reported here that marrow cells appear to be restricted to generate either 
(Phe, G)-  or Pro--L-specific antibodies,  and  raises  the possibility  that  bone 
marrow precursors of antibody-synthesizing ceils  are more restricted in  their 
antigen reactivity than are thymocytes. Irrespective of whether thymus cells 
"recognize" all of the immunogen or only a part of it, the strong association be- 
tween  (Phe,G)- and Pro--L  specific antibody production, when the immune 
system was  limited by thymocytes, implies that  a  single population of such 
cells is activated by (Phe,G)-Pro--L. 
It  is  interesting that  the  frequency of thymocytes relevant for generating 
(Phe,G)-Pro--L responses (1 per 1-2  X  107 thymus cells)  in SJL and DBA/1 
mice is similar to the frequency values obtained in other mouse strains for thy- 
mic antigen-reactive cells  responsive to sheep erythrocyte antigens  (23,  27). 
If a complex immunogen such as sheep erythrocytes (SRBC) can be assumed to 
possess more antigenic determinants than the branched chain synthetic poly- 
peptides (38,  39), then one would expect to detect a higher total frequency of 
thymocytes for SRBC than for (Phe, G)-Pro--L, providing that a separate popu- 
lation of thymus cells exists for each determinant. If, on the other hand,  the 
thymus-derived population of cells does not distinguish between individual de- 
terminants irrespective of the total number of determinants present, then about 
equally frequent populations of thymocytes would be expected to be stimulated 
by either a complex or a simple immunogen, as was demonstrated. 
The possibility exists that expression of the genetic defect could reside at the EDNA  MOZES  AND  G.  M.  SHEARER  157 
level of the thymus-derived cell, and that this defect would not necessarily be 
detected by transplanting  graded numbers of thymocytes. For example, if the 
low responses were to result from different rates of proliferation of equal num- 
bers of preexisting thymic antigen-reactive cells in the two mouse strains, then 
r~o differences would be detected in the initial numbers of responding thymo- 
cytes. The differences in the proliferative capacities of these cells would then 
become.apparent only some time after they had been triggered by the immuno- 
gen. The identical frequencies obtained for (Phe, G)  and Pro--L responses by 
dilution of thymus-derived cells from spleens of irradiated recipients 1 wk after 
injection of 35  X  106 thymocytes and  (Phe,G)-Pro--L indicate that  the low 
response of SJL to (Phe,G) and of DBA/1  to Pro--L cannot be attributed to 
differences in the rates of proliferation of (Phe, G)- or Pro--L-specific thymus- 
derived precursors. Furthermore, the dependence of  (Phe-G)  and  Pro--L  re- 
sponses for thymus-derived cells in both mouse strains  (Table VI)  indicates 
that  the  descendents  of thymic antigen-reactive cells do  not  distinguish  be- 
tween (Phe, G) and Pro--L. In other words, a single population of thymus-derived 
cells generates distinct (Phe, G)- and Pro--L-specific responses, probably via 
interaction with separate monospecific populations of marrow precursors. From 
these results it can be concluded that the thymus population of immunocom- 
petent cells does not acquire greater restriction with respect to antigenic speci- 
ficity after exposure to immunogen. The equal frequencies of thymocytes and 
thymus-derived cells  obtained for (Phe, G)  and Pro--L within the two mouse 
strains, and the strong association observed for these responses, makes it diffi- 
cult to visualize how genetic regulation of responses for two immunopotent re- 
gions within the same macromolecule could be attributed to a cell population 
which  itself  does  not  distinguish  between  these  two  imnmnopotent  areas. 
Nevertheless, these experiments do not necessarily exclude other cellular aspects 
which might relate genetic control of responsiveness to thymocytes. 
Cells contained in bone marrow have been found to be restricted for antibody 
class (26), allotype (40), and determinant specificity (this study). Marrow-de- 
rived elements are also known to be the precursors of plaque-forming cells (31), 
and appear to contain at least one population of rosette-forming cells (11). It is 
not known whether all of the above-mentioned functions are characteristic of a 
single marrow cell type, or whether they are distributed among subpopulations 
in the marrow. Genetic controls of immunity have been considered to be due to 
defects in the antigenic recognition and/or the antibody production phases of 
immune responses (16,  41). The experiments presented in this report demon- 
strate a genetic defect at the level of the bone marrow population(s) of immuno- 
competent precursors, but not at the thymocyte level. Such thymus-marrow 
transfer experiments, however, do not necessarly permit conclusions to be drawn 
regarding  these  so-called  "regcognition"  or  "production"  steps.  Although 
thymocytes appear to be antigen-specific (3, 7, 9, 22, 23), and do not generate 158  CELLULAR  BASIS  OF  GENETIC  CONTROL  OF  IMMUNITY 
antibody-forming cells (42, 43), whereas marrow elements are the precursors of 
plaque-forming cells (31),  it cannot be excluded that  bone marrow cells also 
play an active role in recognition. In fact, results of recent studies indicate the 
presence of specific precursors in bone marrow (9-11, 34). Since marrow contains 
cells possessing the properties of recognition and of antibody production, it is 
not possible from the data presented here to determine whether the immuno- 
logical genetic defect for  (Phe,G)-Pro-L is  one  of antigenic  recognition,  of 
antibody production,  or  of both.  Evidence has  been  presented suggesting  a 
three cell antigen-sensitive unit (2,4); two of these cells appear to be marrow- 
derived and independent of the thymus (4). Thus, it is possible either that one 
marrow cell is concerned with recognition and the other with antibody produc- 
tion,  or that a  single  marrow cell type functions both for recognition and for 
antibody production. Should the latter possibility be correct and the genetic 
control of  (Phe, G)-Pro--L responses  be  associated  exclusively with  marrow, 
then it would not be possible to distinguish defects involving recognition from 
those  involving production. 
SUMMARY 
Previous cellular studies on the genetic regulation of immunological respon- 
siveness for two immunopotent  regions within  the branched chain synthetic 
polypeptide  (Phe,G)-Pro--L  demonstrated  a  direct  correlation  between  the 
number of detectable immunocompetent splenic precursor cells and the response 
patterns of SJL, DBA/1,  and F1 mice (21). In order to establish  the cellular 
origin(s) of the genetic defect, the present study first demonstrated that thymus 
and  bone  marrow  cell cooperation was  required  for  (Phe,G)-  and  Pro-L- 
specific immune responses.  Secondly, limiting dilution experiments,  in  which 
several graded and limiting inocula of marrow cells were mixed with  a  non- 
limiting number of l0  s thymocytes and injected into irradiated,  syngeneic re- 
cipients, indicated that the low responsiveness of the SJL and DBA/1 strains to 
the  (Phe, G)  and Pro--L specificities, respectively, cmfld be attributed to a re- 
duced number of precursor ceils  found in bone marrow. About five times more 
marrow precursors were detected in  SJL  mice for Pro--L than  for (Phe,G), 
whereas about five times as many precursor cells were estimated for (Phe, G) 
as for Pro--L in the DBA/1  strain.  These differences are similar to those ob- 
tained using spleen cells from unimmunized SJL and DBA/1 donors (21), and 
indicate that these genetically determined variations in responsiveness can be 
accounted for  by differences in  the  frequencies  of  monospecific populations 
of immunocompetent cells present in bone marrow. 
In contrast, limiting dilution transfers of thymocytes or thymus-derived cells 
with an excess of syngeneic marrow cells resulted in equally frequent (Phe, G) 
and Pro-L responses for both SJL ad DBA/1 strains. This finding in conjunc- 
tion with the observation that the generation of (Phe, G)- and Pro--L-specific EDNA  MOZES  AND  G.  M.  SHEARER  159 
responses were associated in individual recipients injected with limiting inocula 
of thymocytes indicated that a single population of thymocytes was stimulated 
by (Phe, G)-Pro--L. Therefore, it is improbable that  the  thymic population of 
immunocompetent cells contributes to expression of these genetically controlled 
defects. 
The authors express their gratitude to Prof. Michael Sela for stimulating discussions, and 
to Mrs. Heidy Zinger for excellent technical assistance. 
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